Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
3.3
2.8
Journals
Current Oncology
Announcements
share announcement

Announcements

1 August 2024
Current Oncology | World Lung Cancer Day


World Lung Cancer Day is marked on 1st August every year with the aim of raising awareness about lung cancer and promoting prevention, screening, and treatment. This global event seeks to increase public understanding of the risk factors associated with lung cancer and drive governments, organizations, and individuals to take action in order to reduce the incidence and mortality rates of lung cancer. We would like to take this opportunity to express our gratitude to all of the researchers who have contributed to this field. In particular, we would like to share some of the innovative research findings and a high-quality Special Issue in the related fields published in Current Oncology (ISSN: 1718-7729). We hope this announcement will provide useful information for this field.

“Non-Small-Cell Lung Cancer in 2022: A Review for General Practitioners in Oncology”
by Hamid Mithoowani and Michela Febbraro
Curr. Oncol. 2022, 29(3), 1828–1839; https://doi.org/10.3390/curroncol29030150
Available online: https://www.mdpi.com/1718-7729/29/3/150

“ROS-1 Fusions in Non-Small-Cell Lung Cancer: Evidence to Date”
by Sébastien Gendarme, Olivier Bylicki, Christos Chouaid and Florian Guisier
Curr. Oncol. 2022, 29(2), 641–658; https://doi.org/10.3390/curroncol29020057
Available online: https://www.mdpi.com/1718-7729/29/2/57

“Uncommon EGFR Compound Mutations in Non-Small Cell Lung Cancer (NSCLC): A Systematic Review of Available Evidence”
by Ilaria Attili, Antonio Passaro, Pasquale Pisapia, Umberto Malapelle and Filippo de Marinis
Curr. Oncol. 2022, 29(1), 255–266; https://doi.org/10.3390/curroncol29010024
Available online: https://www.mdpi.com/1718-7729/29/1/24

“Novel Harmonization Method for Multi-Centric Radiomic Studies in Non-Small Cell Lung Cancer”
by Marco Bertolini, Valeria Trojani, Andrea Botti, Noemi Cucurachi, Marco Galaverni, Salvatore Cozzi, Paolo Borghetti, Salvatore La Mattina, Edoardo Pastorello, Michele Avanzo et al.
Curr. Oncol. 2022, 29(8), 5179–5194; https://doi.org/10.3390/curroncol29080410
Available online: https://www.mdpi.com/1718-7729/29/8/410

“Real-World Clinical Outcomes after Genomic Profiling of Circulating Tumor DNA in Patients with Previously Treated Advanced Non-Small Cell Lung Cancer”
by Steven Olsen, Jiemin Liao and Hidetoshi Hayashi
Curr. Oncol. 2022, 29(7), 4811–4826; https://doi.org/10.3390/curroncol29070382
Available online: https://www.mdpi.com/1718-7729/29/7/382

“Stage III Non-Small-Cell Lung Cancer: An Overview of Treatment Options”
by Francesco Petrella, Stefania Rizzo, Ilaria Attili, Antonio Passaro, Thomas Zilli, Francesco Martucci, Luca Bonomo, Filippo Del Grande, Monica Casiraghi, Filippo De Marinis et al.
Curr. Oncol. 2023, 30(3), 3160–3175; https://doi.org/10.3390/curroncol30030239
Available online: https://www.mdpi.com/1718-7729/30/3/239

“Cost Savings of Expedited Care with Upfront Next-Generation Sequencing Testing versus Single-Gene Testing among Patients with Metastatic Non-Small Cell Lung Cancer Based on Current Canadian Practices”
by Brandon S. Sheffield, Kiefer Eaton, Bruno Emond, Marie-Hélène Lafeuille, Annalise Hilts, Patrick Lefebvre, Laura Morrison, Andrea L. Stevens, Emmanuel M. Ewara and Parneet Cheema
Curr. Oncol. 2023, 30(2), 2348–2365; https://doi.org/10.3390/curroncol30020180
Available online: https://www.mdpi.com/1718-7729/30/2/180

“Immunotherapy in Early-Stage Non-Small Cell Lung Cancer (NSCLC): Current Evidence and Perspectives”
by Chiara Lazzari, Calogera Claudia Spagnolo, Giuliana Ciappina, Martina Di Pietro, Andrea Squeri, Maria Ilenia Passalacqua, Silvia Marchesi, Vanesa Gregorc and Mariacarmela Santarpia
Curr. Oncol. 2023, 30(4), 3684–3696; https://doi.org/10.3390/curroncol30040280
Available online: https://www.mdpi.com/1718-7729/30/4/280

Relevant Special issue:
“Current State of Immunotherapy for Lung Cancer”
Guest Editor: Prof. Dr. Barbara Melosky

You are welcome to submit relevant papers to the journal Current Oncology. For any questions, feel free to contact us.

Current Oncology Editorial Office

More News...
Back to TopTop